Critical Contrast: BioLife Solutions (NASDAQ:BLFS) and Nanosonics (OTCMKTS:NNCSF)

BioLife Solutions (NASDAQ:BLFS) and Nanosonics (OTCMKTS:NNCSF) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends and institutional ownership.

Insider and Institutional Ownership

93.2% of BioLife Solutions shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares BioLife Solutions and Nanosonics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioLife Solutions	-59.88%	-10.75%	-8.89%
Nanosonics	N/A	N/A	N/A

Earnings and Valuation

This table compares BioLife Solutions and Nanosonics”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLife Solutions	$139.96 million	8.43	-$66.43 million	($1.69)	-15.12
Nanosonics	N/A	N/A	N/A	N/A	N/A

Nanosonics has lower revenue, but higher earnings than BioLife Solutions.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for BioLife Solutions and Nanosonics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLife Solutions	0	0	6	0	3.00
Nanosonics	0	0	0	0	N/A

BioLife Solutions presently has a consensus target price of $26.67, indicating a potential upside of 4.33%. Given BioLife Solutions’ higher possible upside, analysts clearly believe BioLife Solutions is more favorable than Nanosonics.

Summary

BioLife Solutions beats Nanosonics on 5 of the 8 factors compared between the two stocks.

About BioLife Solutions

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

About Nanosonics

Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.